UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000046124 |
|---|---|
| Receipt number | R000052646 |
| Scientific Title | Intraocular pressure-lowering effect of ripasudil hydrochloride hydrate for glaucoma |
| Date of disclosure of the study information | 2021/11/20 |
| Last modified on | 2021/11/19 20:10:06 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Intraocular pressure-lowering effect of ripasudil hydrochloride hydrate for glaucoma
Acronym
Intraocular pressure-lowering effect of ripasudil hydrochloride hydrate for glaucoma
Scientific Title
Intraocular pressure-lowering effect of ripasudil hydrochloride hydrate for glaucoma
Scientific Title:Acronym
Intraocular pressure-lowering effect of ripasudil hydrochloride hydrate for glaucoma
Region
| Japan |
Condition
Condition
glaucoma
Classification by specialty
| Ophthalmology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate the effect of ripasudil on glaucoma
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Intraocular Pressure
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
ripasudil eye drops
Interventions/Control_2
operation
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 100 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Glaucoma
Key exclusion criteria
Patient who can not use eye drops.
Target sample size
20
Research contact person
Name of lead principal investigator
| 1st name | Tatsuya |
| Middle name | |
| Last name | Mimura |
Organization
Teikyo University
Division name
School of Medicine, Department of Ophthalmology
Zip code
173-8605
Address
2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8605 Japan
TEL
03-3964-1211
mimurat@med.teikyo-u.ac.jp
Public contact
Name of contact person
| 1st name | Tatsuya |
| Middle name | |
| Last name | Mimura |
Organization
Teikyo University
Division name
School of Medicine, Department of Ophthalmology
Zip code
173-8605
Address
2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8605 Japan
TEL
0339641211
Homepage URL
mimurat@med.teikyo-u.ac.jp
Sponsor or person
Institute
Teikyo University School of Medicine, Department of Ophthalmology
Institute
Department
Personal name
Funding Source
Organization
Teikyo University School of Medicine, Department of Ophthalmology
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Teikyo University
Address
Department of Ophthalmology
Tel
0339641211
mimurat@med.teikyo-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 11 | Month | 20 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2018 | Year | 01 | Month | 01 | Day |
Date of IRB
| 2018 | Year | 01 | Month | 01 | Day |
Anticipated trial start date
| 2018 | Year | 01 | Month | 01 | Day |
Last follow-up date
| 2024 | Year | 01 | Month | 01 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2021 | Year | 11 | Month | 19 | Day |
Last modified on
| 2021 | Year | 11 | Month | 19 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052646
